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Summary 
We report that the growth cones of Xenopus retinal 
ganglion cells express fibroblast growth factor recep- 
tors (FGFRs) and that bFGF stimulates neurite exten- 
sion from cultured retinal neurons. Furthermore, bFGF 
is abundant in the developing optic tract but is reduced 
in the optic tectum. To test whether FGF signaling 
plays a role in axonal guidance in vivo, bFGF was exog- 
enously applied to the developing optic pathway in 
"exposed brain" preparations. FGF-treated retinal ax- 
ons navigate normally through the optic tract, but the 
majority veer aberrantly at the tectal border and by- 
pass the target. Our results implicate FGF signaling in 
target recognition and suggest that diminished levels 
of bFGF in the tectum cause arriving axons to slow 
their growth. 
Introduction 
To advance through its environment, an axon needs to 
extend and to steer. These behaviors are mediated by 
the axon's growth cone, which detects and responds to 
molecules in the neuroepithelium (see reviews by Dodd 
and Jessell, 1988; Bixby and Harris, 1991; Goodman and 
Shatz, 1993). Upon reaching its target, the axon stops 
advancing and begins to arborize (Harris et al., 1987; 
Kaethner and Stuermer, 1992). Changes in the expression 
of molecules in the growth cone could cause this abrupt 
modification in behavior (Becker et al., 1993; de Curtis 
and Reichardt, 1993; Liu et al., 1993; Meier et al., 1993). 
Alternatively, target recognition could require specific mol- 
ecules present in the target (Baier and Bonhoeffer, 1992; 
Perez and Halfter, 1993; Yamagata and Sanes, 1995). A 
number of different classes of molecule have been impli- 
cated as target recognition signals, including cell and sub- 
strate adhesion molecules and soluble factors (Tessier- 
Lavigne and Placzek, 1991; Goodman and Shatz, 1993). 
Growth factors may serve as targeting molecules, in that 
they are often expressed in the target (Campenot, 1994) 
and can affect neurite extension, branching, and steering 
(Campenot, 1977; Gundersen and Barrett, 1979; Zhang 
et al., 1994), We are particularly interested in the family 
of fibroblast growth factors (FGFs), whose members are 
known to promote proliferation, survival, and differentia- 
tion of various neuronal types (Sensenbrenner, 1993; Ma- 
son, 1994). The possibility that FGF plays a role in steering 
and target recognition in vivo has not been tested, yet 
there is evidence to support this idea. For instance, acidic 
(aFGF or FGF-1) and basic (bFGF or FGF-2) fibroblast 
growth factor influence both neurite outgrowth (Walicke 
et al., 1986; Rydel and Greene, 1987; Hatten et al., 1988; 
Lipton et al., 1988; Walicke, 1988; Zhou and DiFiglia, 
1993) and the expression of extracellul~r matrix molecules 
in the environment hrough which axons grow (Drago et 
al., 1991; Kinoshita et al., 1993; Meiners, et al., 1993; 
Rettig et al., 1994). In addition, recent evidence implicates 
FGF signaling in cell migration (Kinoshita et al., 1993; 
Reichman et al., 1994). 
To test the idea that FGFs are important for axon naviga- 
tion, we chose the developing Xenopus visual system for 
several reasons. The behavior of Xenopus retinal ganglion 
cell (RGC) axons is well characterized (Chien et al., 1993); 
the Xenopus embryo is especially amenable to these types 
of analyses; and FGF signaling is thought to play a role 
in RGC differentiation (Heuer et al., 1990; Wanaka et al., 
1991; Tcheng et al., 1994). In addition, message for FGFs 
and the FGF receptor (FGFR) is expressed in the devel- 
oping Xenopus visual system (Friesel and Brown, 1992; 
I~aacs et al., 1992; Tannahill et al., 1992; Song and Slack, 
1994), implicating FGFs in the establishment of the optic 
pathway. 
Of the nine known members of the FGF family, bFGF 
has been particularly well studied in Xenopus because 
of its involvement in mesoderm induction (Kimelman and 
Kirschner, 1987; Slack et al., 1987; Amaya et al., 1993). 
Additionally, bFGF may serve atrophic function for RGCs, 
since, in other species, it is expressed in differentiating 
RGCs (de Longh and McAvoy, 1993) and may be involved 
in the determination of the neural retina (Park and Hollen- 
berg, 1989; Pittack et al., 1991). Furthermore, mammalian 
retinal culture data indicate that aFGF and bFGF increase 
RGC survival (Bahr et al., 1989) and the subsequent ex- 
pression of differentiated markers by RGCs (Guillemot and 
Cepko, 1992). Finally, in vivo, RGCs bind bFGF and can 
transport it either in an anterograde (Ferguson et al., 1990) 
or a retrograde fashion (Sievers et al., 1987). Thus, bFGF 
is a strong candidate for having a role in RGC axon growth 
and guidance in vivo. 
In this study, we investigate the role of bFGF in the 
formation of the retinotectal projection by determining the 
distribution of bFGF and FGFR in the developing visual 
system; the effect of bFGF on RGCs in vitro; and the effect 
of exogenous bFGF applied to the optic pathway and to 
RGC somata using an in vivo exposed brain preparation 
(Chien et al., 1993). Our results suggest a role for bFGF 
and the FGFR in axonal targeting in the developing Xeno- 
pus visual system. 
Results 
Basic FGF is Abundant in the Optic Tract 
but Low in the Tectum 
The first retinal axons enter the optic chiasm at stage 32 
and cross into the contralateral brain at stage 33/34. These 
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Figure 1. Normal bFGF and FGFR Expression 
in the Brain and Localization of Ecotopic bFGF 
(A) Transverse section through the diencepha- 
Ion and tectum of a stage 39embryo immune- 
stained with a rabbit polyclonal antibody 
against Xenopus bFGF. The neuropil (Np) and 
cell bodies in the diencephalon are intensely 
labeled, but only weak labeling is seen in the 
tectum (Tec). Dotted line demarcates boundary 
between immunopositive and immunonegative 
regions and roughly marks the diencephalic- 
tectal border. 
(B) Whole-mount brain stained with anti-bFGF. 
All major axon tracts are labeled (TPOC, tract 
;" FGFR D Np ~l f f - .~-  of the posterior optic commissure; TPC, tract of 
'J the posterior commissure; AOC, anterior optic 
commissure). By contrast, immunostaining is 
reduced in the tectum, especially in the midre- 
OP ;~lf~ ~ gion. 
"t 
(C) Transverse section through the diencepha- 
, Ion of a stage 39 Xenopus embryo immune- 
stained with a polyclonal ntibody against Xen- 
opus FGFR. 
(D and E) FGFR immunostaining (D) and anti- 
Np HRP double-labeled RGC axons (E) from the 
b~. boxed region i  (C) demonstrating that FGFR 
. . . . .  ~' ' Np staining colocalizes with the RGC axons. 
; ~. i ~• (F) Section through the midbrain of an embryo 
-- exposed to 100 ng/ml bFG F for 6 hr and stained 
with anti-bFGF. Punctate labeling is seen on 
the exposed side (see arrows), incontrast o the unexposed side. V, ventricle; Di, diencephalon; Pi, pineal; op, optic axons. Bar in (A), 50 pm (for 
A, C, and F) and 120 p.m (for B). Bar in (D), 20 p_m (for D and E). 
- ~ bFGF-Treate( 
V Tec 
Di ~. ~. 
c p ~r '~ 
axons then grow dorsalward through the diencephalon to 
form the optic tract, and they begin to innervate the tectum 
at stage 37/38 (Holt, 1984). To investigate the distribution 
of bFGF in the developing visual system, we stained trans- 
verse sections of stage 33/34-39 brains and eyes with a 
polyclonal antibody against Xenopus bFGF (XbFGF). At 
all stages examined, this antibody labels the neuropil and 
cell somata in the diencephalon (Figure 1A). In fact, the 
entire pathway of RGC axons, including the optic tract, 
optic nerve, and optic nerve head, is immunopositive for 
bFGF. The neuropil remains immunopositive for bFGF in 
brains enucleated at stage 30 by removing the contralat- 
eral eye, indicating that bFGF is present in the substrate 
in the absence of retinal fibers. The target of RGC axons, 
the optic tectum, is only weakly labeled by anti-bFGF, as 
seen in cross section (Figure 1A) and in a whole-mount 
brain (Figure 113). Similar immunostaining was observed 
with a rabbit polyclonal antibody against rat bFGF. In 
whole mount, it is obvious that other axon tracts in the 
brain are labeled by anti-bFGF, including the tract of the 
posterior optic commissure (TPOC), the anterior optic 
commissure (AOC), and the tract of the posterior commis- 
sure (TPC) (Figure 1 B). These results suggest that retinal 
fibers and axons in other tracts extend in a bFGF-rich 
environment. In the case of the visual system, the optic 
fibers then encounter a bFGF-poor region upon entering 
their target. 
RGC Growth Cones Express FGFRs and Bind bFGF 
Since bFGF is expressed in the optic pathway, we investi- 
gated whether RGC axons and growth cones express 
FGFRs by staining stage 25 eye explant cultures with a 
polyclonal antibody that recognizes extracellular and cyto- 
plasmic portions of the Xenopus FGFR (Amaya et al., 
1991). Both the axons and growth cones of RGCs are 
immunopositive for the FGFR (Figure 2A). Immunostain- 
ing in the axon and growth cone is punctate, indicative of 
receptor clustering. Staining is present in the main body 
of the growth cone, in the lamellopodia, and in some filo- 
podia. To confirm that retinal fibers express the FGFR in 
vivo, transverse sections of stage 39 embryos were 
stained with anti-FGFR. Within the diencephalon and tec- 
tum, this antibody stains the neuropil, cell profiles, and 
radially arranged processes (Figure 1C). FGFR is also ex- 
pressed in the RGC layer, the optic nerve head, and optic 
nerve (data not shown). Double immunolabeling of HRP- 
filled optic projections hows that anti-HRP and anti-FGFR 
staining colocalize (compare Figures 1D and 1E) indicat- 
ing that retinal axons express FGFRs. 
To determine whether growth cones bind exogenous 
bFGF, eye explant cultures were treated with 20 ng/ml 
bFGF and immunostained with anti-bFGF (Figure 2C). The 
lamellopodia and filopodia of RGC growth cones are 
stained in a punctate fashion. Comparable labeling is ob- 
served using nonpermeabilized staining conditions, indi- 
cating that the staining is extracellular. Specificity of the 
staining was demonstrated by the fact that the labeling 
was almost eliminated by preabsorption of the bFGF anti- 
body for 1 hr with 50 ng/ml of XbFGF (data not shown). 
In dissociated cultures, the intensity of bFGF staining of 
retinal growth cones correlated with exogenous bFGF be- 
ing present; cultures treated with bFGF were more in- 
tensely labeled than those grown in serum and embryo 
extract, which in turn were stained more brightly than 
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Figure 2. RGC Growth Cones in Culture Have FGFRs and Respond to bFGF 
RGC growth cones from 24 hr retinal explant cultures double labeled with RITC-conjugated phalloidin (B and D) and anti-FGFR (A) and anti-bFGF 
(C). The immunostaining pattern for bFGF and FGFR are very similar. In both cases, punctate labeling is present in the lamellopodia and filopodia 
of the growth cone and along the axon shaft. The arrow in (A) points to two FGFR clusters in the leading filopodium. Graph (E) shows the mean 
length of the longest neurite of RGCs growing in 24 hr dissociated cultures with and without human bFGF (20 ng/ml). The cultures treated with 
bFGF have significantly onger neurites than those grown without bFGF (*, p < .0001, unpaired two-tailed t test), n is the total number of neurites 
counted from 4 independent experiments (total of 8 cultures counted for each condition), and error bars are SEM. Bar in (B), 5 #m. 
those cultures grown without serum or bFGF (data not 
shown). These data suggest that at least part of the label- 
ing of RGC axons is due to exogenous bFGF; thus, not 
only do RGC growth cones have FGFRs, but they also 
bind bFGF. 
Basic FGF Stimulates Neurite Outgrowth 
from Retinal Cells In Vitro 
Since RGC growth cones express FGFRs, we investigated 
whether bFGF can stimulate neurite outgrowth from Xeno- 
pus RGCs in culture. Dissociated retinal cultures were 
grown for 24 hr inL15 media and 0.1% bovine serum 
albumin (BSA), either with (+bFGF) or without (-bFGF) 
20 ng/ml human bFGF. RGCs were identified morphologi- 
cally as those cells with large, phase-bright cell bodies 
(diameter of 15-20 pm) and 1-2 processes; immunostain- 
ing of dissociated cultures with an antineurofilament anti- 
body verified that these cells were RGCs (Szaro et al., 
1989). Only RGCs whose cell bodies were isolated from 
other cells were used for neurite measurements. The 
mean neurite length in bFGF-treated cultures was over 
twice the length of RGC neurites grown without bFGF (Fig- 
ure 2E) and, in fact, was greater than that measured for 
serum-treated cultures (data not shown). These results 
indicate that bFGF stimulates extension of neurites from 
RGCs. 
Exogenously Applied bFGF Disrupts Targeting 
of RGC Axons In Vivo 
Our data indicate that RGCs express FGFRs, bFGF stimu- 
lates neurite extension, and bFGF localizes discretely 
within the visual system with strong expression in the optic 
pathway but not the tectum. These results led us to investi- 
gate what happens to retinal axon growth and navigation 
when the specific pattern of bFGF expression is disrupted 
by exogenously applying bFGF to the entire developing 
optic pathway. Using an exposed brain preparation (Chien 
et al., 1993), a recombinant form of XbFGF (100 ng/ml) 
was applied to the brain of stage 33/34 embryos. At this 
stage, the first RGC axons have crossed the optic chiasm 
and entered the base of the optic tract in the contralateral 
brain. At stage 40, we filled the RGC fibers with HRP to 
visualize the optic projection. 
Representative optic projections of control, epidermal 
growth factor-treated, and XbFGF-treated embryos are 
shown in Figure 3. In control embryos, neither the expo- 
sure nor the BSA carrier had any effect on the optic projec- 
tions, which were very similar to those of unexposed con- 
trols (data not shown). The control optic projection takes 
a stereotypical route, making a wide 45 ° posterior turn 
in the middiencephalon; then running in a dorsal-caudal 
direction; and finally entering the tectum and arborizing 
(seen in Figures 3A and 3B). Figures 3D-3F show the optic 
projections of embryos that developed in the presence 
of XbFGF. The XbFGF-treated axons pathfind normally 
through the diencephalon. However, when they reach the 
diencephalon-midbrain border, most XbFGF-treated 
RGC axons fail to enter the tectum and instead veer ven- 
trally or dorsally around it (Figure 3E and 3F). Treated 
fibers did not appear to branch, but since single retinal 
axons grew in either direction, the optic projections were 
often seen to bifurcate at the tectal entry point. This pheno- 
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Figure 3. Exogenous Basic FGF Causes RGC Axons to Bypass the Tectum 
Control retinal projection (A and B) and retinal projections in brains exposed to 250 ng/ml EGF (C) and 100 ng/ml XbFGF (D-F). Panels (B) and 
(E) are higher magnification Nomarski images of (A) and (D), respectively. Control optic projections enter the tectum (Tec), the anterior and posterior 
borders of which are marked with arrowheads. EGF-treated optic projections are normal (C). In contrast, the majority of bFGF-treated axons fail 
to enter and grow past the tectum (D-F). Axons head either dorsally or ventrally around the tectal border, often resulting in a split optic projection. 
Aberrant behavior at the tectal border can be severe, as seen in (F) where the RGC fibers make an abrupt change m direction and fail to enter 
the target. Ot, optic tract; Di, diencephalon; Tel, telencephalon; Hb, hindbrain. Bar in (C), 100 pm (for A, C, and D) and 50 #m (for B, E, and F). 
type, in which RGC f ibers fail to recogn ize  the tectum as 
their  target, occurred in 82% of cases (37/45). 
To determine whether  the exogenous  bFGF enters  the 
neuroepi the l ium,  we stained t ransverse  sect ions of brains 
exposed  for 6 hr to bFGF with ant i -bFGF (see Figure 1F). 
Exogenous  bFGF label ing is punctate,  penetrates  as far 
as the ventr icu lar  surface, and is found within the dien- 
cephalon,  forebrain,  midbrain,  and h indbra in on the ex- 
posed side of the brain. Similar staining is seen for brains 
exposed  to bFGF for 20 hr (data not shown)• These data 
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indicate that exogenous bFGF is present in the optic tec- 
turn, where it is expressed normally at low levels. 
Trajectories of Mistargeted Axons 
Retinal axons growing through a brain treated with bFGF 
exhibit a range of mistargeting phenotypes. First, the ma- 
jority of axons fail to enter the target, and the optic projec- 
tion bifurcates around the tectum (Figure 4A). Second, 
some fibers do enter the tectum but either stall, grow in 
abnormal directions, or grow out of the target (see arrows 
and arrowheads in Figure 4A). Fibers that stall remain 
in a ventral location, stopping approximately 50-100 ~m 
distant from the area of the tectum they would normally 
innervate. Other fibers make abrupt turns and grow either 
dorsally or ventrally, and commonly exit the tectum. Third, 
axons grow beyond the target along either the rostral or 
ventral border of the tectum. Axons that head dorsally 
along the rostral border often continue across the dorsal 
midline into the contralateral brain (58%, 26/45 brains). 
This results in a striking phenotype with retinal axons form- 
ing a commissural tract across the dorsal midline of the 
diencephalon (Figure 4B). Finally, axons turn orthogonally 
and grow deep in the brain. Normally, RGC axons grow 
close to the pia in the optic tract and never invade the 
ventricular zone (Silver and Rutishauser, 1984; Bovolenta 
and Mason, 1987; Easter and Taylor, 1989; Holt, 1989). 
However, some bFGF-treated optic fibers grow deep in 
the brain neuroepithelium, sometimes even reaching the 
ventricular surface (Figure 4C). Axons headed deep in 
9/9 transversely sectioned bFGF-treated brains, in con- 
trast to 0/4 control brains. Thus, mistargeted axons 
showed a range of aberrant trajectories, with growth 
around the tectal border being the predominant behavior. 
Dose-Dependence of the bFGF-Induced 
Mistargeting Phenotype 
The frequency of the mistargeting phenotype was deter- 
mined for different doses of bFGF (Figure 5A). The strong- 
est effect of bFGF is seen at 50-100 ng/ml, though optic 
projections treated with 10 ng/ml frequently bifurcated 
around the tectum (see Figure 4A). Similar results were 
seen with a human recombinant form of bFG F at a concen- 
tration of 100 ng/ml (data not shown). Even at doses as 
low as 1 ng/ml of XbFGF, many of the axons turn aberrantly 
near the diencephalic-tectal border and grow either dor- 
sally or ventrally. Other behaviors, such as axons crossing 
the midline, require higher doses of bFGF; at 50 ng/ml, 
the majority of treated optic projections cross the midline. 
Because exogenous bFGF has to cross 2-10 ~m of neu- 
roepithelium to reach the RGC growth cones, the absolute 
concentration of bFGF at the axon tip is unknown. How- 
ever, the dose is within the range we and others have 
found has effects in culture experiments. 
Quantitation of Mistargeted Projections 
To quantitate the bFGF-induced phenotype, the width of 
control and bFGF-treated optic projections was measured 
(Figure 5B). Figure 5C shows the mean width plotted as 
a function of the distance along the optic projection. In 
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Figure 4. Three Different Aspects of Aberrant Targeting 
Camera lucida representations of the optic projections of control and 
bFGF-treated brains from a lateral view (A), viewed dorsally (B), and 
in transverse section (C). (A) Trajectories of optic fibers at the border 
between the diencephalon and the tectum. The control axons grow 
into the tectal mass before arborizing. The majority of XbFGF-treated 
fibers grow either dorsally (*) or ventrally (A) around the rectum. Some 
fibers enter the rectum but either stall in ventral regions of the tectum 
(arrowheads), or exit the tectum ventrally (arrows). Dotted lines show 
the approximate borders of the rectum. 
(B) The XbFGF-treated optic projection crosses the dorsal midline and 
enters the contralateral brain. 
(C) The control optic projection isrestricted to the pial surface, whereas 
fibers treated with XbFGF can grow deep in the brain, sometimes 
reaching the ventricular surface. 
Vent, ventricle; Pi, pineal; ot, optic tract; Tec, tectum; Tel, telencepha- 
Ion; D, dorsal; V, ventral; L, lateral; A, anterior; P, posterior. 
control brains, the optic projection widens gradually within 
the diencephalon and widens further upon entering the 
tectum as retinal fibers branch and arborize. The graph 
reveals two aspects of the bFGF phenotype. First, optic 
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Figure 5. Quantitation of the Mistargeting Phenotype 
(A) The percentage of optic projections that bypass the tectum at differ- 
ent concentrations of Xenopus bFGF. Mistargeted projections were 
those where the majority of axons grew around the target, with few 
or no axons entering the tectum. 
(B) Projection width was used to quantitate the bypass phenotype as 
described in the Experimental Procedures. Method of analysis for a 
control brain and a brain treated with 10 ng/ml bFGF is shown. A 
standard reference line (1 bru) was drawn between the optic chiasm 
and the midbrain-hindbrain sthmus (Chien et al., 1993). Concentric 
circles were placed at 0.1 intervals and centered at the optic chiasm, 
and the widest projection width was measured for bins centered on 
each concentric circle (e.g., bin 0.1 comprises the region between 
0.05 and 0.15 bru). Boxes demarcate the outermost parts of the projec- 
tion for each bin. 
(C) Mean optic projection widths (brus have been converted to microns, 
with 1 bru = 620 pro, Chien et al., 1993). Control (n = 32), 1 ng/ml 
(n = 11), 10 ng/ml (n = 19), and 100 ng/ml (n = 29). Basic FGF-treated 
projections are significantly narrower in the diencephalon (tested at 
186 pro) and significantly wider at the tectal border as compared with 
control projections (* *, p < .005, * * * p < .0001, unpaired two-tailed 
t test). Errors bars are SEM and, if not visible, are smaller than the 
symbols. 
projections treated with 100 ng/ml of bFGF are signifi- 
cantly narrower than control projections within the dien- 
cephalon (as seen at 186 p~m). Second, as the optic projec- 
tion approaches the tectum (370 ~tm), it becomes 
significantly wider in bFGF-treated brains (1, 10, and 100 
ng/ml) than in control brains, as a result of treated optic 
projections splitting around and bypassing the tectum. 
Other Growth Factors Do Not Affect 
Target Recognition 
To test the specificity of the bFGF effect, other growth 
factors were used in the exposed brain preparation. Nerve 
growth factor (NGF) and epidermal growth factor (EGF) 
are found in Xenopus (Carriero et al., 1991; Lee et al., 
1993) and are expressed, along with their respective re- 
ceptors, in the eyes of other species (Anchan et al., 1991; 
Zanellato et al., 1993). In bath experiments, NGF (n = 4) 
and EGF (n = 10), at concentrations of up to 250 ng/ml, 
had no effect on the optic projection, in terms of either 
pathfinding or target recognition. A brain treated with EGF 
(250 ng/ml) is shown in Figure 3C. Activin, known to be 
a powerful mesodermal inducer in Xenopus (Thomsen et 
al., 1990), similarly had no effect (5 nM; Andreas Walz, 
personal communication). A human recombinant form of 
aFGF caused axons to bypass the tectum, but with a some- 
what different phenotype from that induced by bFGF. Un- 
like the phenotype observed with bFGF treatment, fibers 
rarely grew ventrally; instead, the RGC axons grew dor- 
sally along the rostral border of the tectum, often entering 
the tectum at a more dorsal location than normal. High 
concentrations (500 ng/ml) of aFGF were needed to gener- 
ate this phenotype reliably. Thus, the tectal bypass effect 
is not general ly caused by growth factors, but appears to 
be specific to FGF and particularly sensitive to bFGF. 
Late Application of bFGF Causes Targeting Errors 
To elucidate further how exogenous bFGF affects optic 
fibers, we determined how late bFGF could be applied to 
the optic projection and still cause axons to miss the target. 
If bFGF is applied at stage 35136, when the first axons 
have reached the middiencephalon, many retinal fibers 
miss the target (95% of cases, n = 19), as seen in Figure 
6A. However, the optic projections of brains treated after 
the first fibers have arrived at the target (stage 37•38) show 
a mixture of normal axons and axons exhibit ing a mistar- 
geting phenotype (Figure 6B). Most optic projections have 
axons that grow into the appropriate area of the tectum 
(91%, n = 22), yet many axons are misdirected: over 50% 
of the optic projections have axons that grow around the 
tectal border, or enter and then exit the target. In addition, 
in many optic projections (82%, n = 22), fibers turned 
and headed either dorsally or ventrally, a behavior that is 
observed rarely in control projections (13%, n = 22). 
These results indicate that the onset of action of bFGF 
must be fairly rapid (within 2 -3  hr), since bFGF is effective 
even though the majority of axons are approaching the 
tectal entry point at stage 37/38. They also suggest that 
retinal fibers do not use each other to recognize the tec- 
turn, since some optic fibers are misdirected despite the 
existence of retinal axons in the target that have appropri- 
ately innervated the tectum. 
Somatic Application of bFGF Does Not 
Cause Mistargeting 
Exogenous bFGF could influence either the RGC growth 
cones or the environment through which they grow. If 
bFGF causes mistargeting by acting directly on RGC ax- 
ons, then exposing RGC somata to exogenous bFGF 
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Figure 6. Application of bFGF to Axons, but not Somata, Elicits Mistar- 
geting Response within Hours 
Camera lucida representations of the brain and optic projection of 
stage 40 embryos exposed to 100 ng/ml bFGF either at stage 35/36 
when the first RGC axons are making the turn in the middiencephalon 
(A) or at stage 37/38 when RGC axons first begin to enter the tectum 
(B). Mistargeted axons turn and grow dorsally or ventrally around the 
tectal border, or exit the tectum upon entering (see arrowheads). Panel 
(C) shows an optic projection of a stage 40 embryo whose eye was 
exposed to bFGF at stage 33/34. Basic FGF acting on the somata 
does not cause mistargeting Arrows mark the approximate borders 
of the tectum, and open circles mark the presumptive diencephalic- 
midbrain border. 
might similarly affect the optic projections. RGCs take up 
bFGF and anterogradely transport it to their nerve termi- 
nals (Ferguson et al., 1990). In addition, ciliary neuro- 
trophic factor affects synaptic transmission regardless of 
whether it is applied to the soma or to the nerve terminal 
(Stoop and Poo, 1995). However, we found that exposing 
the RGC somata to bFGF by removing the lens at stage 
33/34 had no effect on the optic projections, which in 90% 
of cases (28/31) resembled those in control (Figure 6C). 
These results indicate that exogenous bFGF exerts its 
action not on the cell body but on the growth cone, either 
directly or through changes in the neuroepithelial sub- 
strate. 
Basic FGF Does Not Change the Gross Identity 
of the Target 
Next,  we asked whether  exogenous  bFGF alters the prop- 
erties of the neuroepithel ia l  substrate.  S ince bFGF is 
known to stimulate proliferation, increased mitosis in the 
tectum could produce an immature tectum that the retinal 
fibers might not be able to recognize. We compared the 
number of proliferating cells in bFGF-treated and control 
tecta. EGF-treated brains were used as a positive control 
since EGF, also a mitogen, has no effect on target recogni- 
tion (see Figure 3C). Both bFGF and EGF cause a small 
increase in the number of BrdU-labeled cells in the mid- 
brain region including the tectum (Table 1 ). However, the 
approximate 2-fold increase corresponds to less than 1% 
of the total number of cells in the midbrain at this stage 
( -  20,000 cells). In addition, there is no evidence of ectopic 
hotspots of proliferation anywhere in the treated brains. 
Because EGF causes a similar increase in proliferation, 
but has no effect on the optic projection, it is unlikely that 
bFGF causes axons to avoid the tectum by stimulating 
proliferation. 
To investigate further whether the identity of the tectum 
is altered with bFGF treatment, we used immunocyto- 
chemistry and Western analysis to investigate possible 
changes in levels of the homeobox protein engrailed, 
which is expressed in a posterior to anterior gradient in 
the Xenopus tectum (Hemmati-Brivanlou etal., 1991). En- 
grailed protein levels in bFGF-treated brains were 108% 
- 8% of control levels (mean ± SEM, 5 independent 
experiments), indicating that bFGF does not alter en- 
grailed expression. In addition, we examined whether ten- 
ascin expression in the tectum is altered by bFGF- 
treatment. Tenascin is an extracellular matrix molecule 
expressed in the chick tectum that inhibits RGC neurite 
outgrowth in culture (Perez and Halfter, 1993; Taylor et 
al., 1993) and whose levels are upregulated in astrocytes 
by bFGF (Meiners et al., 1993). We used an antibody 
against Xenopus tenascin to immunostain control and 
bFGF-treated whole-mount brains and found that bFGF 
does not obviously affect the intensity or pattern of tenas- 
cin labeling (data not shown). Thus, at least two tectal 
molecules continue to be expressed at normal evels, indi- 
cating that bFGF does not change the gross identity of 
the target. 
Discussion 
Three main results implicate bFGF in guiding retinal ax- 
ons. First, endogenous bFGF shows a regionalized istri- 
Table 1. Basic FGF and EGF Cause a Small Increase in Cell 
Proliferation in the Tectum 
Condition Control bFGF EGF 
Number of BrdU- 
labeled cells per 42 _+ 6 88.6 _+ 11 (*) 124 __. 19 (**) 
embryo 
The number of BrdU-labeled cells was counted in midbrain sections 
of control, bFGF-, and EGF-treated embryos. A total of 4 sections was 
counted for each embryo, and data show the mean number of cells 
counted for each embryo. Control, n = 4 embryos; XbFGF, n = 5 
embryos; EGF, n = 4 embryos. EGF and XbFGF caused small but 
significant increases (*, p < .05; * *, p < .01 ; Dunnett multiple compari- 
sons test) in the number of proliferating cells as compared with control. 
Errors are SEM. 
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bution in the visual pathway with high levels in the optic 
tract and low levels in the optic tectum. Second, the growth 
cones of retinal axons express FGFRs, and cultured retinal 
neurons respond to bFGF by increased neurite outgrowth. 
Third, ectopic bFGF causes retinal axons to veer in abnor- 
mal directions at the diencephalic-midbrain boundary 
and, consequently, to bypass the optic tectum. Together, 
these results suggest that bFGF normally acts to stimulate 
the extension of axons through the optic tract and that a 
reduction of this growth factor in the tectum may play a 
role in target recognition. 
In the exposed brain preparation used here, both the 
retinal axons and their cellular substrate are simultane- 
ously exposed to the bathing medium, making it difficult 
to determine which population of cells bFGF exerts its 
action on. Thus, the axon mistargeting phenotype de- 
scribed here could be mediated indirectly by bFGF- 
induced changes in the tectum or directly by action on the 
retinal axons. A number of pieces of evidence favor the 
idea that axon mistargeting is a result of bFGF acting di- 
rectly on retinal axons. First, RGC growth cones express 
the FGFR, and in culture bFGF stimulates neurite exten- 
sion. Second, the bFGF effect occurs rapidly, within a cou- 
ple of hours, as applying bFGF when retinal fibers are 
reaching the tectum still causes mistargeting of some ax- 
ons. Third, our data indicate that bFGF does not alter the 
gross molecular identity of the tectum in that some tectal 
molecules, such as tenascin and engrailed, are expressed 
normally. In this respect, we also show that it is unlikely 
that ectopic bFGF drives the tectal primordium into an 
immature and thus unrecognizable state, as EGF has a 
similar effect to bFGF in terms of cell proliferation but not 
target recognition. Nonetheless, the possibility remains 
that bFGF could act on FGFRs expressed in the tectum 
and alter the expression of as yet unidentified target mole- 
cules, perhaps upregulating the expression of an inhibitory 
molecule (Baler and Bonhoeffer, 1992; Perez and Halfter, 
1993; Nose et al., 1994). 
As retinal axons navigate through the diencephalon, 
they must receive signals that tell them to grow and signals 
that tell them to steer. Our data suggest that bFGF acts 
as a growth stimulatory molecule. The presence of bFGF 
in the optic tract and, indeed, in other developing axon 
tracts (TPOC, TPC, and AOC) raises the possibility that 
bFGF acts to stimulate the extension of RGC axons in 
vivo. We show that RGC axons and growth cones express 
FGFRs and that in vitro bFGF stimulates a 2-fold increase 
in the length of retinal neurites, both of which lend support 
to this idea. Furthermore, suramin, a reagent known to 
block the action of bFGF, inhibits the extension of axons 
in the optic tract (McFarlane et al., 1993, Soc. Neurosci., 
abstract). Previously, aFGF has been shown to stimulate 
axon outgrowth from RGCs (Lipton et al., 1988). If, indeed, 
the role of endogenous bFGF is to stimulate axon growth 
within the optic tract, rather than to guide, then application 
of exogenous bFGF would not be expected to cause mis- 
routing in this area. Our finding that axon trajectories are 
normal in the optic tract when bFGF is added is consistent 
with this. 
Previous timelapse imaging studies of Dil-filled growth 
cones have shown that retinal axons abruptly change their 
behavior when leaving the optic tract and entering the 
tectum (Harris et al., 1987). They advance through the 
optic tract rapidly (50-80 p~m/hr) with expanded and com- 
plex growth cones. On nearing and entering the target, 
they slow down, lose their expanded tips, and begin to 
arborize by elaborating back branches. These two distinct 
modes of behavior are likely to be regulated by molecular 
cues in the pathway and target. The regionalized istribu- 
tion of bFGF in the optic pathway, bFGF-rich in the tract 
and bFGF-poor in the tectum, raises the possibility that 
the transition between high and low levels of growth factor 
at the tectal border might trigger retinal axons to slow their 
growth and switch from a rapidly extending to an arborizing 
mode of growth. The idea that an axon recognizes its tar- 
get by registering a concentration difference of growth 
factor between its growth cone and the target is also sug- 
gested by studies in transgenic mice that show that sympa- 
thetic axons made to overexpress NGF reach their NGF- 
expressing targets but fail to innervate them appropriately 
(Hoyle et al., 1993). 
If the role of bFGF is to stimulate extension of retinal 
axons, one might expect that bath application of bFGF, 
which introduces bFGF to both the optic tract and the tec- 
tum, would smooth out regionalized ifferences in bFGF 
and cause axons to grow indiscriminately through the tec- 
turn. instead, our results show that retinal axons turn and 
avoid entering the tectum in the presence of exogenous 
bFGF. This result is clearly puzzling. One possible expla- 
nation is that the reduced levels of bFGF encountered 
normally at the tectum act not only to slow axons down, 
but also to modify their responsiveness to certain target 
molecules. This change may be required for the retinal 
axons to invade the tectum, a region which expresses 
several inhibitory molecules (Baier and Bonhoeffer, 1992; 
Perez and Halfter, 1993; Luo et al., 1995). In bFGF-treated 
brains, RGC axons would not receive the necessary signal 
at the target border and thus would remain unresponsive 
to the target and grow preferentially in areas that are per- 
missive to axon extension. Such regions would include 
areas where axons of other tracts are actively extending, 
such as the TPC and TPOC. In fact, following surgical 
ablation of the target, RGC axons follow the TPC and 
TPOC that are present along the rostral and ventral bor- 
ders of the tectum, respectively (Taylor, 1990). 
Recently, it has been postulated that the FGFR acts as 
a downstream signaling molecule for cell adhesion mole- 
cules (CAMs; Williams et al., 1994). Experiments uggest 
that CAMs promote retinal axon outgrowth in vivo and in 
vitro (Neugebauer et al., 1988; R. Riehl, personal commu- 
nication). In addition, overexpression of Fas II, a Drosoph- 
ila CAM homolog, in motoneuron growth cones causes 
the axons to mistarget in a similar fashion to retinal fibers 
treated with bFGF (Lin and Goodman, 1994). These au- 
thors hypothesize that increased fasciculation between 
axons prevents them from reading cues in their environ- 
ment and finding their target. Growth factors can increase 
neurite fasciculation (Ure et al., 1992); therefore, an alter- 
native mechanism for the retinal axon mistargeting is that 
exogenous bFGF mimics CAM signaling and increases 
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fasciculation. Interestingly, within the diencephalon, bFGF- 
treated optic projections are significantly narrower than 
controls, suggesting that the tracts are more tightly fascic- 
ulated. 
There are at least three different types of FGFR (John- 
son and Williams, 1993), including a family of membrane 
receptor tyrosine kinases (RTKs), heparan sulfate proteo- 
glycans (HSPGs), and a cysteine rich FGFR (Burrus et 
al., 1992). The activated FGFR is currently thought to exist 
as a ternary complex of the high affinity RTK, a low affinity 
HSPG, and FGF. Thus, the mere presence of bFGF does 
not always guarantee a function, since biological activity 
depends on its ability to bind specific cell surface or extra- 
cellular matrix HS (Neufeld et al., 1987; Klagsbrun, 1990; 
Givol and Yayon, 1992; Nurcombe et al., 1993). This raises 
the possibility that heparin, a member of the HS family, 
might mimic bath application of bFGF by releasing bFGF 
bound to HSPG and redistributing it within the brain 
(Flaumenhaft et al., 1990; Givol and Yayon, 1992). Indeed, 
heparin also causes mistargeting of retinal axons (McFar- 
lane et al., 1993, Soc. Neurosci., abstract). The heparin 
and bFGF results support the idea that bFGF normally 
interacts with specific HSPGs to provide localized signals 
for growth of RGC axons and that disruption of this pattern 
causes axons to miss their target. 
The FGFR family of RTKs consists of at least four recep- 
tor types, and different FGFs can activate the same type 
of receptor (Givol and Yayon, 1992; Johnson and Williams, 
1993). This promiscuity may be important, since a number 
of different FGFs have been identified in Xenopus, includ- 
ing bFGF (Kimelman and Kirschner, 1987; Slack et al., 
1987), FGF-3 (Tannahill et al., 1992), and XeFGF, an em- 
bryonically expressed FGF homologous to FGF-4 and 
FGF-6 (Isaacs et al., 1992). FGF-3 and XeFGF are coex- 
pressed with FGFR-2 at the back of the tectum (Friesel and 
Brown, 1992; Isaacs et al., 1992; Tannahill et al., 1992); 
therefore, it is possible that exogenous bFGF mimics the 
action of an endogenous FGF other than bFGF. 
Soluble growth factors probably act as specific growth 
stimulatory molecules along the pathways of many axons. 
Recently, a number of soluble molecules secreted by tar- 
get cells and deposited in the extracellular matrix have 
been shown to act as chemoattractant molecules (see re- 
view in Tessier-Lavigne, 1994). At least one growth factor, 
brain-derived neurotrophic factor, is expressed in the Xen- 
opus tectum (Cohen-Cory and Fraser, 1994), but at a later 
stage when RGC axons have already reached the tectum. 
In fact, in the developing Xenopus visual system, experi- 
mental evidence does not support the existence of a tar- 
get-derived attractant factor (Harris et al., 1985; Taylor, 
1990). Certainly, since bFGF levels are low in the tectum, 
bFGF does not appear to serve this function. We suggest 
alternatively, that the absence of a specific growth factor 
in the target that was present in the pathway may signal 
to axons that they have reached their destination. 
Experimental Procedures 
Animals 
Eggs were obtained from adult Xenopus laevis stimulated to breed 
by treatment with human chorionic gonadotropin. Embryos were raised 
in 10% Holtfreter's olution (Holtfreter, 1943) at 14°C-25°C and 
staged according to the Nieuwkoop and Faber staging tables (Nieuw- 
koop and Faber, 1967). 
Retinal Cell Cultures 
Eye primordia were dissected from stage 25 embryos and cultured 
as described previously (Harris et al., 1985; Harris and Messersmith, 
1992). Dissociated cells or entire eyes were plated onto polyornithine/ 
laminin-coated coverslips in 35 mm petri dishes containing 2 ml of 
culture media. Culture media consisted of 60% L15 (CORE cell culture 
facility, UCSD) supplemented with 10% fetal bovine serum (Gemini 
Products), 1% tungibact (CORE cell culture facility), and 1% embryo 
extract (Harris et al., 1985). Some cultures were grown in the absence 
of serum and embryo extract, and in either the presence or absence 
of 20 ng/ml human recombinant bFGF (GIBCO) and 0.1% BSA (frac- 
tion V, Fisher Scientific). Dissociated and explant cultures were fixed 
for 45 rain in 2% paraformaldehyde. Neurites were drawn using cam- 
era lucida and measured using a flexible ruler. 
Bathing Media and Growth Factors 
The exposed brain preparation was performed largely as described 
previously (Chien et al., 1993). Briefly, embryos were anesthetized in 
modified Barth's saline (Gurdon, 1977) supplemented with 0.4 rng/ml 
tricaine (ethyl 3-aminobenzoate methanesulfonie acid, Aldrich), 1% 
Fungibact, 50 mg/ml gentamicin sulfate (Gemini Products), and 10 
mg/rnl phenol red. The embryos were pinned in a Sylgard dish (K. R. 
Anderson Co.), and the skin and eye over the left brain were removed. 
This procedure xposes the entire anterior brain on one side, reaching 
as far caudal as the posterior ectum. Surgery was performed on all 
embryos before they were randomly divided to develop in either experi- 
mental or control solutions for another 18-24 hr until stage 40. Control 
bath solution consisted of modified Barth's saline (pH 7.4), 0.1 mg/ml 
tricaine, and 0.1% BSA. To make the experimental bath solutions, 
different growth factors were added to this control solution: recombi- 
nant XbFGF (0.05-5 nM, 1-100 ng/ml, kindly provided by both J. Slack 
and D. Kimelman); human bFGF (100 ng/ml); EGF (100-500 ng/ml, 
murine natural, GIBCO); 7S NGF (250 ng/ml, murine natural, GIBCO); 
and aFGF (100-500 ng/ml, human recombinant, GIBCO). 
Visualization of the Optic Projection 
To visualize the optic projection, RGC axons were labeled using horse- 
radish peroxidase (HRP, type VI; Sigma) as described previously (Cor- 
nel and Holt, 1992). The lens of the right eye was surgically removed 
and HRP, dissolved in 1% lysolecithin, was placed in the eye cavity. 
After allowing time for anterograde labeling of RGCs (25 min), embryos 
were fixed at room temperature in 1% gluteraldehyde in0.1 M sodium 
phosphate buffer (pH 7.4). After fixation, brains were washed in phos- 
phate-buffered saline, reacted with diaminobenzidine (Sigma), dehy- 
drated through a graded series of alcohols, and cleared in 2:1 benzyl 
benzoate:benzyl a cohol. They were mounted in Permount (Fisher Sci- 
entific) under a coverstip supported by two plastic reinforcement rings 
(Avery). The outlines of brains and optic projections were drawn using 
a camera lucida attachment on a Leitz microscope. 
Quantitation of Optic Projection Width 
Width measurements were made along the full contralateral extent of 
optic projections in control and bFGF-treated brains. Camera lueida 
representations ofmounted brains were scanned (Scan Jet IIc, Hewlett- 
Packard) to provide digital images. Samples were used only if they 
were mounted without significant rolling and had well-filled optic pro- 
jections. Analysis was performed on a Macintosh Quadra 700 com- 
puter using the public domain NIH Image program (National Institutes 
of Health). Macros were used to normalize brain size by rotating and 
scaling them to a line drawn between the anterior optic chiasm and 
the midbrain-hindbrain isthmus and matching this line to a standard 
reference line (Chien et al., 1993). The optic ehiasm and the isthmus 
were chosen as easily identified and reliable morphological markers 
in the Xenopus brain. The reference line was used to define an artificial 
unit, a brain reference unit (bru); one bru is -620 pm in an unfixed 
brain (Chien et al., 1993). This unit line was divided into 0.1 intervals 
through which concentric circles were drawn (see Figure 5B). The 
projection width was measured as the widest part of the tract within 
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bins centered around each concentric circle (for example, 0.5-0.15, 
0.15-0.25, etc.). The lateral boundaries of the projection were defined 
by the presence of >3 axons. 
Immunofiuorescence 
Fixed embryos were washed in 0.1 M sodium phosphate buffer (pH 
7.4). Some were sunk in 30% sucrose, embedded in optimal cutting 
temperature (Baxter), and quick frozen at -20°C; and 12 I~m sections 
were cut on a Slee cryostat and collected on gelatin-coated slides. 
Others had their brains dissected out and processed as whole mounts. 
Standard immunostaining procedures were used for cryostat sections, 
whole-mount brains, and cultures (Cornel and Holt, 1992). Samples 
were incubated overnight at 4°C in the primary antibody diluted in 
PBT (phosphate buffered saline, 0.2% BSA, with or without 0.2% Tri- 
ton X-100; Sigma)with 5o/0 goat serum (Gemini Products). Samples 
were incubated with a secondary fluorescent antibody for 1 hr at room 
temperature. After washing, samples were mounted in glycerol with 
an antibleaching agent, p-phenylenediamine (1 mg/ml in 9 parts glyc- 
erol, 1 part 1 M Tris-HCI; pH 8.5; Sigma). Cultures were frequently 
counterstained with RITC-conjugated phalloidin (Sigma) added to the 
secondary incubation at a dilution of 1:100, to help visualize growth 
cones. Samples were photographed either with a camera attachment 
on a Zeiss Axioskop or using a cooled CCD camera (Spectrasource) 
attached to a Nikon optiphot-2 microscope. Photographs taken with the 
CCD camera were captured using a Gateway 2000 PC and processed 
using NIH Image and Adobe Photoshop software. 
Antibodies 
We used a rabbit polyclonal anti-Xenopus bFGF antibody (provided 
by D. Kimelman) that recognizes a protein of 19 kDa (corresponding 
to bFGF) on a Western blot (data not shown). The specificity of the 
antibody was demonstrated by successful elimination of the 19 kDa 
band by preabsorption of the antibody with bFGF for 2 hr at room 
temperature. For immunostaining and Western blots, the serum anti- 
body was diluted 1:500 with PBT and 5% goat serum and then preab- 
sorbed with a homogenate of - 30 embryos (stages 30-40) in a volume 
of 1 ml for 2 hr at room temperature. This procedure eliminated back- 
ground staining on the Western. For FGFR labeling, we used an affin- 
ity-purified rabbit polyclonal antibody against the Xenopus FGFR (T. 
Musci; Amaya et al., 1993) at a concentration of 1:400. This antibody 
was generated against a glutathione transferase partial FGFR fusion 
protein that includes most of the external portion of the FGFR, the 
transmembrane domain, and a portion of the intracellular domain in- 
cluding the tyrosine kinase domains (Amaya et al., 1991). Occasion- 
ally, eyes were filled with HRP before fixation. Double labeling with 
an antibody against HBP (Sigma, dilution 1:500) and either anti-bFGF 
or anti-FGFR allowed visualization of the optic projection relative to 
bFGF and FGFR staining. A rabbit polyclonal antibody against Xeno- 
pustenascin (kindly provided by J. Riou)was used at a dilution of 1:250. 
Fluorescein isothiocyanate-conjugated or rhodamine isothiocyanate- 
conjugated goat antirabbit secondary antibodies (Jackson Labora- 
tories) were used at a dilution of 1:500. A monoclonal antibody against 
the engrailed protein (4D9, provided by N. Patel) was used for immuno- 
cytochemistry and Western analysis at a dilution of 1:500. For analysis 
of engrailed levels, Western blots were scanned to make digital im- 
ages, and the intensity of the bands was determined using NIH Image 
gel analysis macros. 
BrdU Labeling 
Brains were exposed to control, bFGF (100 ng/ml) or EGF (200 ng/ 
ml) solutions at stage 33•34. At stage 39, the gut of each embryo was 
injected with 5 mg/ml BrdU diluted in water and phenol red (to visualize 
injections). Three hours after injection, embryos were fixed in 4% para- 
formaldehyde for 4 hr at room temperature and processed for paraffin 
sectioning. Sections (12 ~m)were im munostained as described above. 
An anti-BrdU monoclonal antibody (Sigma) was used at a dilution of 
1:10. The secondary was a rhodamine isothiocyanate-conjugated 
goat antimouse antibody used at a dilution of 1:500. Photos of serial 
sections were taken and BrdU-positive ceils were counted in every 
second section starting from the midbrain- hindbrain isthmus (back of 
tectum) and moving in an anterior direction. For each embryo a total 
of 4 sections were analyzed. 
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